European Healthtech startup funding raised during Q3 2010.
In Q3 2010, 15 European Healthtech companies raised a combined €80M across 15 funding rounds, up 35.0% versus Q3 2009. UK led by capital raised, and Amundi Private Equity Funds was the most active investor. Data as of 7 Aug 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Kymab | Series A | Jul 2010 | €25M |
| EarlySense | Series C | Jul 2010 | €11M |
| uTest_Vamsi | Series C | Sep 2010 | €10M |
| Protagen | Series B | Sep 2010 |
| €10M |
| Global Imaging Online | Early VC | Jul 2010 | €4.8M |
| Alyotech | Early VC | Jul 2010 | €4.0M |
| Camero;Inc | Early VC | Aug 2010 | €3.1M |
| WiThings | Series A | Sep 2010 | €3.0M |
| Anaconda Pharma | Other | Jul 2010 | €2.9M |
| Phagenesis | Other | Sep 2010 | €2.8M |
| InSphero | Series A | Aug 2010 | €1.3M |
| Reapplix | Early VC | Sep 2010 | €1.0M |
| Acuitas Medical | Early VC | Jul 2010 | €856k |
| Scopis | Seed | Sep 2010 | €394k |
| Masquemedicos | Other | Sep 2010 | €42k |
